Japanese Scientists Take a Historic Step Toward Treating Down Syndrome

In a remarkable breakthrough, Japanese researchers have successfully removed the extra chromosome responsible for Down syndrome using cutting-edge CRISPR gene-editing technology, restoring normal function in affected cells.

Led by Dr. Ryotaro Hashizume at Mie University, the team became the first to tackle the root cause of Down syndrome at the cellular level. Their method selectively eliminates the third copy of chromosome 21 while keeping the normal two intact—a milestone in genetic research.

Down syndrome, which affects about 1 in every 700 births worldwide, arises from trisomy 21, where cells carry an extra chromosome 21. This disrupts normal development, leading to intellectual disabilities, unique facial features, and a higher risk of conditions such as heart disease and early-onset Alzheimer’s.

The researchers applied a precise approach called allele-specific editing. This technique instructs CRISPR-Cas9 to target DNA sequences present only on the extra chromosome. Once cut, the unstable chromosome is naturally lost as cells divide.

Laboratory tests showed that this method successfully removed the additional chromosome in 30.6% of cells. Treated cells exhibited normalized gene activity, protein production, and survival—closely resembling healthy cells. Remarkably, the technique was effective in both stem cells and adult skin cells from individuals with Down syndrome.

While it will take several years before this approach can be applied in clinical settings, the study offers a hopeful glimpse into a future where therapies might reduce or even prevent some of the severe health effects associated with Down syndrome.